Cargando...

A new model for end-stage liver disease improves prognostic capability after transjugular intrahepatic portosystemic shunt

BACKGROUND & AIMS: Cirrhotics undergoing transjugular intrahepatic portosystemic shunt (TIPS) for refractory ascites or recurrent variceal bleeding are at risk for decompensation and death. This study examined whether a new model for end-stage liver disease (MELDNa), which incorporates serum sod...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Guy, Jennifer, Somsouk, Ma, Shiboski, Stephen, Kerlan, Robert, Inadomi, John M., Biggins, Scott W.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2009
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2783337/
https://ncbi.nlm.nih.gov/pubmed/19560557
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2009.06.009
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!